In NAFLD, TSP-1 is implicated in stimulating steatosis and steatohepatitis (139), seen by a reduction in lipid accumulation and TNF-α production in TSP-1 deficient mice (139). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.